Ding Li

Dr. Ding Li


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2018 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
QTQi Tang
Qi Tang
QYQi Yuan
Qi Yuan
HLHui Li
Hui Li
WWWanchun Wang
Wanchun Wang
GXGuangrong Xie
Guangrong Xie
DLDing Li
Ding Li

12 May 2019 in Journal of Cellular Physiology
Verified
Journal Article
Closed access
PDF file
DLDing Li
Ding Li
KYKun Yu
Kun Yu
TXTao Xiao
Tao Xiao
YDYilong Dai
Yilong Dai
LLLihong Liu
Lihong Liu
LXLiang Xiong
Liang Xiong


1 June 2019 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
DLDing Li
Ding Li
QYQi Yuan
Qi Yuan
KYKun Yu
Kun Yu
TXTao Xiao
Tao Xiao
LLLihong Liu
Lihong Liu
ALAoyu Li
Aoyu Li

1 June 2024 in Chemical Engineering Journal
Verified
Journal Article
Open access
JLJie Liao
Jie Liao
JZJialin Zhang
Jialin Zhang
JLJianghua Li
Jianghua Li
YZYi Zeng
Yi Zeng
YDYilong Dai
Yilong Dai
Cuie WenCuie Wen
Cuie Wen

2 December 2021 in Frontiers in Endocrinology
Verified
Journal Article
Open access
DLDing Li
Ding Li
QYQi Yuan
Qi Yuan
LXLiang Xiong
Liang Xiong
ALAoyu Li
Aoyu Li
YXYu Xia
Yu Xia
Osteoporosis is a complex multifactorial disorder linked to various risk factors and medical conditions. Bone marrow-derived mesenchymal stem cell (BMSC) dysfunction potentially plays a critical role in osteoporosis pathogenesis. Herein, the study identified that miR-4739 was upregulated in BMSC cultures harvested from osteoporotic subjects. BMSCs were isolated from normal and osteoporotic bone marrow tissues and identified for their osteogenic differentiation potential. In osteoporotic BMSCs, miR-4739 overexpression significantly inhibited cell viability, osteoblast differentiation, mineralized nodule formation, and heterotopic bone formation, whereas miR-4739 inhibition exerted opposite effects. Through direct binding, miR-4739 inhibited distal-less homeobox 3 (DLX3) expression. In osteoporotic BMSCs, DLX3 knockdown also inhibited BMSC viability and osteogenic differentiation. Moreover, DLX3 knockdown partially attenuated the effects of miR-4739 inhibition upon BMSCs. Altogether, the miR-4739/DLX3 axis modulates the capacity of BMSCs to differentiate into osteoblasts, which potentially plays a role in osteoporosis pathogenesis. The in vivo and clinical functions of the miR-4739/DLX3 axis require further investigation.